| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.047 | 0.3 |